BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3857184)

  • 1. Optimal prescription method for cancer chemotherapy.
    Vriesendorp HM
    Exp Hematol; 1985; 13 Suppl 16():57-63. PubMed ID: 3857184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of normal tissue damage induced by cancer chemotherapy.
    Vriesendorp HM; Vriesendorp R; Vriesendorp FJ
    Cancer Chemother Pharmacol; 1987; 19(4):273-6. PubMed ID: 3297374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy toxicity in gynecologic cancer patients with a body surface area (BSA)>2 m2.
    Schwartz J; Toste B; Dizon DS
    Gynecol Oncol; 2009 Jul; 114(1):53-6. PubMed ID: 19359030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flat-fixed dosing versus body surface area based dosing of anticancer drugs in adults: does it make a difference?
    Mathijssen RH; de Jong FA; Loos WJ; van der Bol JM; Verweij J; Sparreboom A
    Oncologist; 2007 Aug; 12(8):913-23. PubMed ID: 17766650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity and dose individualization in cancer chemotherapy: the role of body surface area and body mass index.
    Portugal RD
    Med Hypotheses; 2005; 65(4):748-51. PubMed ID: 15979816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body surface area estimation in children using weight alone: application in paediatric oncology.
    Sharkey I; Boddy AV; Wallace H; Mycroft J; Hollis R; Picton S;
    Br J Cancer; 2001 Jul; 85(1):23-8. PubMed ID: 11437397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of age and chemotherapy on gentamicin pharmacokinetics and dosing in pediatric oncology patients.
    Ho KK; Bryson SM; Thiessen JJ; Greenberg ML; Einarson TR; Leson CL
    Pharmacotherapy; 1995; 15(6):754-64. PubMed ID: 8602384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Greater risks of chemotherapy toxicity in elderly patients with cancer.
    Repetto L
    J Support Oncol; 2003; 1(4 Suppl 2):18-24. PubMed ID: 15346996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body surface area for adjustment of drug dose.
    Drug Ther Bull; 2010 Mar; 48(3):33-6. PubMed ID: 20200147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity.
    Prado CM; Baracos VE; McCargar LJ; Mourtzakis M; Mulder KE; Reiman T; Butts CA; Scarfe AG; Sawyer MB
    Clin Cancer Res; 2007 Jun; 13(11):3264-8. PubMed ID: 17545532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic parameters: potential for and problems with their use as predictors of response to cancer chemotherapeutic agents.
    Creaven PJ
    Bull Cancer; 1979; 66(1):85-8. PubMed ID: 420951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the dose per body weight of conditioning chemotherapy on severity of mucositis and risk of relapse after autologous haematopoietic stem cell transplantation in relapsed diffuse large B cell lymphoma.
    Costa LJ; Micallef IN; Inwards DJ; Johnston PB; Porrata LF; Litzow MR; Ansell SM
    Br J Haematol; 2008 Oct; 143(2):268-73. PubMed ID: 18699848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolving concepts in the systemic drug therapy of breast cancer.
    Norton L
    Semin Oncol; 1997 Aug; 24(4 Suppl 10):S10-3-S10-10. PubMed ID: 9275000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropathy under chemotherapy.
    Beinert T; Masuhr F; Mwela E; Schweigert M; Flath B; Harder H; Binder D; Oehm C; Behse F; Possinger K
    Eur J Med Res; 2000 Oct; 5(10):415-23. PubMed ID: 11076782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cross-sectional study comparing variation in body surface area and chemotherapy dosing in pediatric oncology using two different methods.
    Jastaniah W; Aseeri M
    J Oncol Pharm Pract; 2010 Sep; 16(3):189-93. PubMed ID: 19808711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of implementing a cancer chemotherapy order form on prescribing habits for parenteral antineoplastics.
    Pastel DA; Fay P; Lee D
    Hosp Pharm; 1993 Dec; 28(12):1192-5. PubMed ID: 10130616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose chemotherapy with stem cell reinfusion and growth factor support for solid tumors.
    de Vries EG; de Graaf H; Boonstra A; van der Graaf WT; Mulder NH
    Stem Cells; 1995 Nov; 13(6):597-606. PubMed ID: 8590861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dosage regimen optimization in cancer chemotherapy using a mathematical model].
    Barbolosi D; Freyer G; Ciccolini J; Iliadis A
    Bull Cancer; 2003 Feb; 90(2):167-75. PubMed ID: 12660135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Theory and actual attempts to establish an effective cancer chemotherapy].
    Fujimoto S
    Gan To Kagaku Ryoho; 1997 Feb; 24(4):501-10. PubMed ID: 9063491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer chemotherapy in the older patient: what the medical oncologist needs to know.
    Balducci L; Extermann M
    Cancer; 1997 Oct; 80(7):1317-22. PubMed ID: 9317185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.